Chemical Structure : ALW-II-41-27
CAS No.: 1186206-79-0
货号: PC-45397Not For Human Use, Lab Use Only.
ALW-II-41-27 is an ATP-competitive EPHA2 RTK inhibitor with IC50 of 11 nM.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥1580 | In stock | |
10 mg | ¥2380 | In stock | |
25 mg | ¥3980 | In stock | |
50 mg | ¥5880 | In stock | |
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
ALW-II-41-27 is an ATP-competitive EPHA2 RTK inhibitor with IC50 of 11 nM.
ALW-II-41-27 reduces the number of viable NSCLC cells in a time-dependent and dose-dependent manner in vitro and induces tumor regression in human NSCLC xenografts in vivo.
ALW-II-41-27 decreases both survival and proliferation of erlotinib-resistant tumor cells and inhibits tumor growth in vivo.
ALW-II-41-27 also decreasrd viability of cells with acquired resistance to the third-generation EGFR TKI AZD9291.
分子量 | 607.689 | |
分子式 | C32H32F3N5O2S | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
DMSO: ≥ 47 mg/mL |
|
Chemical Name/SMILES |
Benzamide, N-[4-[(4-ethyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-4-methyl-3-[[[5-(2-thienyl)-3-pyridinyl]carbonyl]amino]- |
1. Choi Y, et al. Bioorg Med Chem Lett. 2009 Aug 1;19(15):4467-70.
2. Amato KR, et al. J Clin Invest. 2014 May;124(5):2037-49.
3. Amato KR, et al. Cancer Res. 2016 Jan 15;76(2):305-18.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright